Vimarsana
Biggest News Aggregation in the World

Page 4 - Column Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Column Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Column Group Today - Breaking & Trending Today

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM -February 27, 2024 at 04:11 pm EST - Vimarsana News

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM -February 27, 2024 at 04:11 pm EST

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of NGM Biopharmaceuticals, Inc. to affiliates of The...

Neurona Therapeutics Raises $120M in Funding - Vimarsana News

Neurona Therapeutics Raises $120M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders - Vimarsana News

Neurona Therapeutics Raises $120M to Advance Groundbreaking Pipeline of Regenerative Cell Therapy Candidates for Chronic Neurological Disorders

SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell ther...

Tenaya Therapeutics Shares Rise 25% After Offering Prices - Vimarsana News

Tenaya Therapeutics Shares Rise 25% After Offering Prices

By Chris Wack Tenaya Therapeutics shares were up 25% at $5.54 after the company priced its underwritten offering of 8.9 million shares at $4.50 a share. The...

Neurona raises another $120M for brain disease cell therapies - Vimarsana News

Neurona raises another $120M for brain disease cell therapies

BioPharma